New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
January 26, 2010
11:32 EDTVVUS
theflyonthewall.com: Merriman: Victoza approval bodes well for Vivus' Qnexa
Merriman believes the approval of Novo Nordisk's GLP-1 analog, Victoza, for the treatment of Type 2 diabetes, bodes well for the approval of Vivus' Qnexa. The firm feels the FDA's ability to put the risk/benefit ratio into the proper perspective suggests that there is no "blanket" regulatory bias for or against drugs for diabetes and obesity. :theflyonthewall.com



News For VVUS From The Last 14 Days
Check below for free stories on VVUS the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 6, 2012
20:16 EDTVVUS
theflyonthewall.com: Jim Cramer's "Mad Money"

Subscribe for More Information
:theflyonthewall.com

January 30, 2012
15:51 EDTVVUS
theflyonthewall.com: Biotech Industry Organization to host a conference

Subscribe for More Information
:theflyonthewall.com